β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma.
Saved in:
| Title: | β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma. |
|---|---|
| Authors: | Mathews P; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Wang X; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Wu J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Jabbar S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Burcher K; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Rein L; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA. |
| Source: | Cells [Cells] 2025 Mar 26; Vol. 14 (7). Date of Electronic Publication: 2025 Mar 26. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40214450 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mathews+P%22">Mathews P</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Jabbar+S%22">Jabbar S</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Burcher+K%22">Burcher K</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Rein+L%22">Rein L</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Kang+Y%22">Kang Y</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101600052%22">Cells</searchLink> [Cells] 2025 Mar 26; Vol. 14 (7). <i>Date of Electronic Publication: </i>2025 Mar 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101600052 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2073-4409 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220734409%22">20734409 </searchLink><i>NLM ISO Abbreviation: </i>Cells <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40214450 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cells14070496 Languages: – Code: eng Text: English Titles: – TitleFull: β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mathews P – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Jabbar S – PersonEntity: Name: NameFull: Burcher K – PersonEntity: Name: NameFull: Rein L – PersonEntity: Name: NameFull: Kang Y IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 03 Text: 2025 Mar 26 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2073-4409 Numbering: – Type: volume Value: 14 – Type: issue Value: 7 Titles: – TitleFull: Cells Type: main |
| ResultId | 1 |